Moral motivation regarding dementia risk testing among affected persons in Germany and Israel

6Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

Abstract

Recent advances in biomarkers may soon make it possible to identify persons at high risk for late-onset Alzheimer's disease at a presymptomatic (preclinical) stage. Popular demand for testing is increasing despite the lack of cure and effective prevention options and despite uncertainties regarding the predictive value of biomarker tests. This underscores the relevance of the ethical, cultural and social implications of predictive testing and the need to advance the bioethical debate beyond considerations of clinical consequences. Our qualitative study included three groups of affected persons: People with mild neurocognitive disorder, their relatives and family caregivers of people with dementia. We explored their moral motivations regarding predictive, biomarker-based testing and preclinical diagnostics. We interviewed affected individuals in Germany and Israel (N=88; 44 participants in each country). Transcripts of 12 focus groups and 12 semistructured interviews were content analysed with a focus on the moral motivations of affected persons in their justification of why they accept or reject predictive testing and early diagnosis. We grouped the underlying aspects of moral motivation into four ethical categories: beneficence as a form of personal utility focusing on well-being, the ties of responsibility linking families and their individual members, the importance of self-determination by later life planning and notions of a good life. In general, cultural parallels among these motives were very obvious. Cultural variation occurred mainly in openness to suicide, scepticism about test validity and emphasis on personal autonomy. The study underscores the importance of counselling for life-planning issues and of informing test candidates about problems with test validity and about the ambiguity of test results.

References Powered by Scopus

Using thematic analysis in psychology

110442Citations
N/AReaders
Get full text

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

6575Citations
N/AReaders
Get full text

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

5588Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta-analysis of empirical data

19Citations
N/AReaders
Get full text

Ethical Aspects of Prodromal Synucleinopathy Prognostic Counseling

6Citations
N/AReaders
Get full text

Counseling and disclosure practices in predictive Alzheimer's disease diagnostics: A scoping review

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Alpinar-Sencan, Z., Schicktanz, S., Ulitsa, N., Shefet, D., & Werner, P. (2021). Moral motivation regarding dementia risk testing among affected persons in Germany and Israel. Journal of Medical Ethics, 48(11), 861–867. https://doi.org/10.1136/medethics-2020-106990

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

36%

Lecturer / Post doc 4

29%

Researcher 3

21%

Professor / Associate Prof. 2

14%

Readers' Discipline

Tooltip

Social Sciences 5

33%

Medicine and Dentistry 4

27%

Nursing and Health Professions 3

20%

Biochemistry, Genetics and Molecular Bi... 3

20%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free